닥플 플러스
2026년도 한국분자·세포생물학회 정기학술대회(4일차)
한국분자세포생물학회
연수평점 :2점
오프라인
주관
한국분자세포생물학회
교육일자
2026-10-08
수강료
470,000원
교육형태
오프라인
등록일시
2026-09-02
교육시간
13시간 55분
연수평점
2점
장소
대전광역시 대전컨벤션센터(DCC) 제 1전시장 컨퍼런스홀 외 5개홀
교육종류
분자생물학
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-10-08 | 09:00~09:50 | We Live in an Imperfect World — and so Do Plants | Detlef Weigel(Max Planck Institute for Biology Tübingen) | - |
| 2026-10-08 | 09:50~10:00 | Break | - | - |
| 2026-10-08 | 10:00~10:30 | Human Metabologenomics for Integration of Multi-Omics Data | Adil Mardinoglu(King's College London / KTH) | - |
| 2026-10-08 | 10:30~11:00 | Decoding and Switching Cell States: from Single-Cell and Spatial Transcriptomic Biomarkers to Bherapeutic Interventions | Sang-Min Park(Chungnam National University) | - |
| 2026-10-08 | 11:00~11:30 | ctDNA as a Potential Biomarker in the Era of Precision Oncology | Tae-You Kim(Seoul National University College of Medicine) | - |
| 2026-10-08 | 11:30~12:00 | GDF15–GFRAL Signaling in Cancer: Bridging Biomarkers and Therapeutic Intervention | Minho Shong(KAIST) | - |
| 2026-10-08 | 10:00~10:15 | Overview of Biomedical Applications of iPSC-Derived Cells and Tissues | Dong Hyun Jo(Seoul National University College of Medicine) | - |
| 2026-10-08 | 10:15~10:40 | Genome Editing Toward Advanced Cell Therapy for Diabetes | Donghyun Lim(Hanyang University) | - |
| 2026-10-08 | 10:40~11:05 | Building Human Skin from iPSCs: Epidermal Organoids and Multipotent Progenitors for Modeling and Regeneration | Jung Woon Lee(KRIBB) | - |
| 2026-10-08 | 11:05~11:30 | Translating iPSC-Derived Retinal Cells into Clinical Applications: Current Status and Future Perspectives | Tadao Maeda(VC Cell Therapy Inc) | - |
| 2026-10-08 | 11:30~11:55 | AI-Driven Prediction and Model Evaluation of iPSC and iPSC-Derived Cells | Hee-Jae Jeon(Kangwon National University) | - |
| 2026-10-08 | 10:00~10:40 | Systematic Comparison of Senolytics Identifies Mitochondrial Quality Control as a Key Determinant of Resistance | Eiji Hara(The University of Osaka) | - |
| 2026-10-08 | 10:40~11:05 | Regulation of Aging by Non-Coding RNA Homeostasis | Seung-Jae V. Lee(KAIST) | - |
| 2026-10-08 | 11:05~11:30 | Aberrant Growth Factor Signaling in Senescence and Cancer | Chanhee Kang(Seoul National University) | - |
| 2026-10-08 | 11:30~11:55 | Decoding Muscle Stem Cell Aging Programs for Rejuvenation Therapy | Jongmin Kang(Sungkyunkwan University School of Medicine) | - |
| 2026-10-08 | 10:00~10:25 | Pathogenic Mechanisms of Mammalian Adaptive North American H5N1 Virus and Control Strategies | Young-Il Kim(KVRI, IBS) | - |
| 2026-10-08 | 10:25~10:50 | De novo Design of a Potent Immuno-Focusing Antigen for Respiratory Syncytial Virus | Young-Chan Kwon(Korea Research Institute of Chemical Technology) | - |
| 2026-10-08 | 10:50~11:15 | The Two Faces of AIM2 in Viral Immunity | Sang Joon Lee(UNIST) | - |
| 2026-10-08 | 11:15~11:40 | Identifying Entry Receptors for Human Coronaviruses | Sanghyun Lee(Brown University) | - |
| 2026-10-08 | 11:40~12:25 | IL–27–Driven Emergency Hematopoiesis Underlies Immunopathogenesis in SFTS | Nam-Hyuk Cho(Seoul National University) | - |
| 2026-10-08 | 10:00~10:30 | RNAi Therapeutics Development Against Hepatic and Extrahepatic Diseases | Dong-ki Lee(Olix Pharmaceuticals / Sungkyunkwan University) | - |
| 2026-10-08 | 10:30~11:00 | Brain Somatic Mosaicism: A Platform for RNA Therapeutic Target Discovery | Jeong Ho Lee(Sovargen Co. LTD / KAIST) | - |
| 2026-10-08 | 11:00~11:30 | From RNA Target Discovery to a microRNA-Degrading ASO Platform: Advancing a Disease-Modifying Therapy for Osteoarthritis | Jin-Hong Kim(Liflex Science / Seoul National University) | - |
| 2026-10-08 | 11:30~12:00 | Catalytic RNA Rewriting: A Programmable Platform for RNA Editing Therapeutics | Seong-Wook Lee(Rznomics Inc./ Dankook University) | - |
| 2026-10-08 | 10:00~10:30 | Brain Delivery of Therapeutics: How Grabody B Employs Transcytosis Pathways | Sungwon An(ABL Bio Inc) | - |
| 2026-10-08 | 10:30~11:00 | OHPAS™, PMT™, and Nexatecan™ Technologies for Enhanced ADC Efficacy and Safety | Yosup Rew(IntoCell) | - |
| 2026-10-08 | 11:00~11:30 | Immuno-Oncology: AR170, a Trispecific Immunocytokine to Redefine Next Generation Cancer Immunotherapy | Bum-Chan Park(Y-Biologics) | - |
| 2026-10-08 | 11:30~12:00 | ABN202 (antibody-interferon-β mutein), a Potent Antibody-cytokine Fusion Protein Platform for the Treatment of Various Solid Tumors | Young Kee Shin(ABION / Seoul National University College of Pharmacy) | - |
| 2026-10-08 | 12:00~13:20 | Break&Lunch | - | - |
| 2026-10-08 | 13:20~14:10 | Non-Human Primate Models for Neurobiology and Biomedical Research | Mu-ming Poo(Institute of Neuroscience, Chinese Academy of Sciences) | - |
비고
<국내> 회원-일반: 사전 23만원, 현장 31만원 회원-학생: 사전 14만원, 현장 19만원 비회원-일반: 사전 38만원, 현장 47만원 비회원-학생: 사전 19만원, 현장 6만원 <해외> 일반: 사전 300달러, 현장 400달러 학생: 사전 160달러, 현장 200달러
문의처
담당자
경현정
연락처
041-55-0316
이메일
hjg0602@pcojeong.com